Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt 2.72
MDSO's Cash-to-Debt is ranked lower than
56% of the 2180 Companies
in the Global Health Information Services industry.

( Industry Median: 5.23 vs. MDSO: 2.72 )
Ranked among companies with meaningful Cash-to-Debt only.
MDSO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.4  Med: 1.36 Max: No Debt
Current: 2.72
0.4
No Debt
Equity-to-Asset 0.69
MDSO's Equity-to-Asset is ranked higher than
66% of the 2115 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. MDSO: 0.69 )
Ranked among companies with meaningful Equity-to-Asset only.
MDSO' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.75  Med: 0.42 Max: 0.69
Current: 0.69
-1.75
0.69
Debt-to-Equity 0.14
MDSO's Debt-to-Equity is ranked higher than
67% of the 1267 Companies
in the Global Health Information Services industry.

( Industry Median: 0.27 vs. MDSO: 0.14 )
Ranked among companies with meaningful Debt-to-Equity only.
MDSO' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.28  Med: 0.17 Max: 1.02
Current: 0.14
-0.28
1.02
Debt-to-EBITDA 0.88
MDSO's Debt-to-EBITDA is ranked higher than
59% of the 1112 Companies
in the Global Health Information Services industry.

( Industry Median: 1.26 vs. MDSO: 0.88 )
Ranked among companies with meaningful Debt-to-EBITDA only.
MDSO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01  Med: 3.77 Max: 7.45
Current: 0.88
0.01
7.45
Interest Coverage 3.24
MDSO's Interest Coverage is ranked lower than
89% of the 1702 Companies
in the Global Health Information Services industry.

( Industry Median: 46.64 vs. MDSO: 3.24 )
Ranked among companies with meaningful Interest Coverage only.
MDSO' s Interest Coverage Range Over the Past 10 Years
Min: 1.31  Med: 3.83 Max: 234.61
Current: 3.24
1.31
234.61
Piotroski F-Score: 5
Altman Z-Score: 11.50
Beneish M-Score: -2.30
WACC vs ROIC
10.39%
11.79%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 8.07
MDSO's Operating Margin % is ranked higher than
62% of the 2144 Companies
in the Global Health Information Services industry.

( Industry Median: 4.91 vs. MDSO: 8.07 )
Ranked among companies with meaningful Operating Margin % only.
MDSO' s Operating Margin % Range Over the Past 10 Years
Min: 5.99  Med: 9.74 Max: 15.64
Current: 8.07
5.99
15.64
Net Margin % 8.17
MDSO's Net Margin % is ranked higher than
68% of the 2144 Companies
in the Global Health Information Services industry.

( Industry Median: 3.58 vs. MDSO: 8.17 )
Ranked among companies with meaningful Net Margin % only.
MDSO' s Net Margin % Range Over the Past 10 Years
Min: 1.82  Med: 7.2 Max: 21.36
Current: 8.17
1.82
21.36
ROE % 9.25
MDSO's ROE % is ranked higher than
59% of the 2062 Companies
in the Global Health Information Services industry.

( Industry Median: 6.36 vs. MDSO: 9.25 )
Ranked among companies with meaningful ROE % only.
MDSO' s ROE % Range Over the Past 10 Years
Min: 2.48  Med: 9.2 Max: 63.95
Current: 9.25
2.48
63.95
ROA % 5.19
MDSO's ROA % is ranked higher than
60% of the 2199 Companies
in the Global Health Information Services industry.

( Industry Median: 2.95 vs. MDSO: 5.19 )
Ranked among companies with meaningful ROA % only.
MDSO' s ROA % Range Over the Past 10 Years
Min: 1.02  Med: 4.75 Max: 22.66
Current: 5.19
1.02
22.66
ROC (Joel Greenblatt) % 53.53
MDSO's ROC (Joel Greenblatt) % is ranked higher than
63% of the 2165 Companies
in the Global Health Information Services industry.

( Industry Median: 23.63 vs. MDSO: 53.53 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MDSO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 53.53  Med: 88.68 Max: 277.92
Current: 53.53
53.53
277.92
3-Year Revenue Growth Rate 14.40
MDSO's 3-Year Revenue Growth Rate is ranked higher than
71% of the 1829 Companies
in the Global Health Information Services industry.

( Industry Median: 6.30 vs. MDSO: 14.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MDSO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -21.7  Med: 14.15 Max: 17.5
Current: 14.4
-21.7
17.5
3-Year EBITDA Growth Rate 29.70
MDSO's 3-Year EBITDA Growth Rate is ranked higher than
80% of the 1588 Companies
in the Global Health Information Services industry.

( Industry Median: 9.10 vs. MDSO: 29.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MDSO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -0.05 Max: 39.1
Current: 29.7
0
39.1
3-Year EPS without NRI Growth Rate 54.60
MDSO's 3-Year EPS without NRI Growth Rate is ranked higher than
89% of the 1432 Companies
in the Global Health Information Services industry.

( Industry Median: 10.70 vs. MDSO: 54.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MDSO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -13.2 Max: 88.8
Current: 54.6
0
88.8
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MDSO's 30-Y Financials

Financials (Next Earnings Date: 2019-04-19)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2018

MDSO Guru Trades in Q1 2018

Eaton Vance Worldwide Health Sciences Fund 82,720 sh (New)
Chuck Royce 715,559 sh (+72.00%)
Pioneer Investments 21,576 sh (+74.65%)
Joel Greenblatt Sold Out
Frank Sands 3,323,809 sh (-6.48%)
» More
Q2 2018

MDSO Guru Trades in Q2 2018

Lee Ainslie 21,600 sh (New)
Chuck Royce 814,615 sh (+13.84%)
Pioneer Investments 23,293 sh (+7.96%)
Eaton Vance Worldwide Health Sciences Fund 82,720 sh (unchged)
Frank Sands 3,258,309 sh (-1.97%)
» More
Q3 2018

MDSO Guru Trades in Q3 2018

Paul Tudor Jones 9,020 sh (New)
Chuck Royce 966,124 sh (+18.60%)
Eaton Vance Worldwide Health Sciences Fund 82,720 sh (unchged)
Lee Ainslie Sold Out
Frank Sands 2,146,654 sh (-34.12%)
Pioneer Investments 17,622 sh (-24.35%)
» More
Q4 2018

MDSO Guru Trades in Q4 2018

Chuck Royce 1,094,146 sh (+13.25%)
Eaton Vance Worldwide Health Sciences Fund 82,720 sh (unchged)
Frank Sands Sold Out
Paul Tudor Jones Sold Out
Pioneer Investments 9,622 sh (-45.40%)
» More
» Details

Insider Trades

Latest Guru Trades with MDSO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services    NAICS: 511210    SIC: 7372
Compare:NAS:HQY, SZSE:300253, NAS:ATHN, NYSE:TDOC, XTER:COP, NAS:PINC, NAS:OMCL, NAS:INOV, HKSE:02666, SZSE:300451, NYSE:EVH, NAS:QSII, NAS:TRHC, NAS:RCM, NAS:HSTM, LSE:EMIS, LSE:CRW, ASX:PME, SZSE:300550, XPAR:CGM » details
Traded in other countries:2M9.Germany,
Headquarter Location:USA
Medidata Solutions Inc provides cloud-based solutions for life sciences. Its customers are pharmaceutical, biotechnology, and medical device companies, academic institutions, and contract research organizations.

Medidata Solutions Inc provides cloud-based solutions for the clinical development programs of life sciences companies. Its customers include biopharmaceutical companies, device makers, contract research organizations, and academic institutions. The majority of the company's business comes from subscriptions to the Medidata Clinical Cloud, with the remainder of revenue coming from services. The Medidata Clinical Cloud provides solutions for study design and planning, data capture, patient activity measurement, risk-based monitoring, and payments. The services segment includes technology and support services and professional consulting services. The majority of the firm's revenue is generated within the United States.

Ratios

vs
industry
vs
history
PE Ratio 89.48
MDSO's PE Ratio is ranked lower than
87% of the 1475 Companies
in the Global Health Information Services industry.

( Industry Median: 24.79 vs. MDSO: 89.48 )
Ranked among companies with meaningful PE Ratio only.
MDSO' s PE Ratio Range Over the Past 10 Years
Min: 11.29  Med: 95.64 Max: 2129.13
Current: 89.48
11.29
2129.13
Forward PE Ratio 43.10
MDSO's Forward PE Ratio is ranked lower than
69% of the 456 Companies
in the Global Health Information Services industry.

( Industry Median: 26.18 vs. MDSO: 43.10 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 89.48
MDSO's PE Ratio without NRI is ranked lower than
88% of the 1414 Companies
in the Global Health Information Services industry.

( Industry Median: 24.46 vs. MDSO: 89.48 )
Ranked among companies with meaningful PE Ratio without NRI only.
MDSO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.29  Med: 95.64 Max: 2129.13
Current: 89.48
11.29
2129.13
PB Ratio 7.31
MDSO's PB Ratio is ranked lower than
79% of the 2262 Companies
in the Global Health Information Services industry.

( Industry Median: 2.93 vs. MDSO: 7.31 )
Ranked among companies with meaningful PB Ratio only.
MDSO' s PB Ratio Range Over the Past 10 Years
Min: 4.53  Med: 9.17 Max: 29.12
Current: 7.31
4.53
29.12
PS Ratio 7.23
MDSO's PS Ratio is ranked lower than
78% of the 2268 Companies
in the Global Health Information Services industry.

( Industry Median: 2.86 vs. MDSO: 7.23 )
Ranked among companies with meaningful PS Ratio only.
MDSO' s PS Ratio Range Over the Past 10 Years
Min: 1.31  Med: 6.5 Max: 12.58
Current: 7.23
1.31
12.58
Price-to-Free-Cash-Flow 94.56
MDSO's Price-to-Free-Cash-Flow is ranked lower than
84% of the 924 Companies
in the Global Health Information Services industry.

( Industry Median: 28.20 vs. MDSO: 94.56 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDSO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.21  Med: 51.26 Max: 268.58
Current: 94.56
13.21
268.58
Price-to-Operating-Cash-Flow 51.74
MDSO's Price-to-Operating-Cash-Flow is ranked lower than
77% of the 1181 Companies
in the Global Health Information Services industry.

( Industry Median: 20.26 vs. MDSO: 51.74 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDSO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.26  Med: 36.38 Max: 135.3
Current: 51.74
10.26
135.3
EV-to-EBIT 67.57
MDSO's EV-to-EBIT is ranked lower than
85% of the 1537 Companies
in the Global Health Information Services industry.

( Industry Median: 18.10 vs. MDSO: 67.57 )
Ranked among companies with meaningful EV-to-EBIT only.
MDSO' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.7  Med: 58.45 Max: 344.6
Current: 67.57
8.7
344.6
EV-to-EBITDA 44.15
MDSO's EV-to-EBITDA is ranked lower than
82% of the 1661 Companies
in the Global Health Information Services industry.

( Industry Median: 14.06 vs. MDSO: 44.15 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDSO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 41.95 Max: 133.6
Current: 44.15
6.8
133.6
EV-to-Revenue 7.02
MDSO's EV-to-Revenue is ranked lower than
75% of the 2327 Companies
in the Global Health Information Services industry.

( Industry Median: 2.52 vs. MDSO: 7.02 )
Ranked among companies with meaningful EV-to-Revenue only.
MDSO' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.5  Med: 6.4 Max: 13
Current: 7.02
1.5
13
PEG Ratio 3.17
MDSO's PEG Ratio is ranked lower than
69% of the 650 Companies
in the Global Health Information Services industry.

( Industry Median: 1.89 vs. MDSO: 3.17 )
Ranked among companies with meaningful PEG Ratio only.
MDSO' s PEG Ratio Range Over the Past 10 Years
Min: 2.05  Med: 7.78 Max: 249.45
Current: 3.17
2.05
249.45
Shiller PE Ratio 156.95
MDSO's Shiller PE Ratio is ranked lower than
93% of the 588 Companies
in the Global Health Information Services industry.

( Industry Median: 33.85 vs. MDSO: 156.95 )
Ranked among companies with meaningful Shiller PE Ratio only.
MDSO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 130.79  Med: 214.03 Max: 1168.14
Current: 156.95
130.79
1168.14
Current Ratio 2.71
MDSO's Current Ratio is ranked higher than
67% of the 2075 Companies
in the Global Health Information Services industry.

( Industry Median: 1.93 vs. MDSO: 2.71 )
Ranked among companies with meaningful Current Ratio only.
MDSO' s Current Ratio Range Over the Past 10 Years
Min: 0.44  Med: 2.27 Max: 3.92
Current: 2.71
0.44
3.92
Quick Ratio 2.71
MDSO's Quick Ratio is ranked higher than
69% of the 2075 Companies
in the Global Health Information Services industry.

( Industry Median: 1.78 vs. MDSO: 2.71 )
Ranked among companies with meaningful Quick Ratio only.
MDSO' s Quick Ratio Range Over the Past 10 Years
Min: 0.44  Med: 2.27 Max: 3.92
Current: 2.71
0.44
3.92
Days Sales Outstanding 75.87
MDSO's Days Sales Outstanding is ranked lower than
59% of the 2082 Companies
in the Global Health Information Services industry.

( Industry Median: 66.86 vs. MDSO: 75.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDSO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.45  Med: 74.33 Max: 90.75
Current: 75.87
45.45
90.75
Days Payable 17.16
MDSO's Days Payable is ranked lower than
80% of the 1870 Companies
in the Global Health Information Services industry.

( Industry Median: 44.89 vs. MDSO: 17.16 )
Ranked among companies with meaningful Days Payable only.
MDSO' s Days Payable Range Over the Past 10 Years
Min: 14.42  Med: 19.82 Max: 39.28
Current: 17.16
14.42
39.28

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.90
MDSO's 3-Year Average Share Buyback Ratio is ranked higher than
52% of the 1507 Companies
in the Global Health Information Services industry.

( Industry Median: -3.30 vs. MDSO: -2.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDSO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -55.7  Med: -3.1 Max: -2.5
Current: -2.9
-55.7
-2.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 25.48
MDSO's Price-to-Net-Current-Asset-Value is ranked lower than
82% of the 1591 Companies
in the Global Health Information Services industry.

( Industry Median: 7.16 vs. MDSO: 25.48 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
MDSO' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 8.77  Med: 22.85 Max: 4775
Current: 25.48
8.77
4775
Price-to-Tangible-Book 11.95
MDSO's Price-to-Tangible-Book is ranked lower than
76% of the 2013 Companies
in the Global Health Information Services industry.

( Industry Median: 4.54 vs. MDSO: 11.95 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MDSO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.33  Med: 10.58 Max: 59.17
Current: 11.95
6.33
59.17
Price-to-Intrinsic-Value-Projected-FCF 3.38
MDSO's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
70% of the 907 Companies
in the Global Health Information Services industry.

( Industry Median: 2.08 vs. MDSO: 3.38 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDSO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 2.98  Med: 4.33 Max: 10.1
Current: 3.38
2.98
10.1
Price-to-Median-PS-Value 1.11
MDSO's Price-to-Median-PS-Value is ranked lower than
60% of the 2062 Companies
in the Global Health Information Services industry.

( Industry Median: 1.00 vs. MDSO: 1.11 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDSO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.97 Max: 1.82
Current: 1.11
0.35
1.82
Price-to-Peter-Lynch-Fair-Value 3.58
MDSO's Price-to-Peter-Lynch-Fair-Value is ranked lower than
84% of the 449 Companies
in the Global Health Information Services industry.

( Industry Median: 1.62 vs. MDSO: 3.58 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MDSO' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 3.21  Med: 6.56 Max: 11.04
Current: 3.58
3.21
11.04
Price-to-Graham-Number 6.90
MDSO's Price-to-Graham-Number is ranked lower than
86% of the 1170 Companies
in the Global Health Information Services industry.

( Industry Median: 2.19 vs. MDSO: 6.90 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MDSO' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.96  Med: 5.99 Max: 14.34
Current: 6.9
1.96
14.34
Earnings Yield (Greenblatt) % 1.47
MDSO's Earnings Yield (Greenblatt) % is ranked lower than
54% of the 2413 Companies
in the Global Health Information Services industry.

( Industry Median: 2.07 vs. MDSO: 1.47 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDSO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.3  Med: 1.7 Max: 11.5
Current: 1.47
0.3
11.5
Forward Rate of Return (Yacktman) % 21.39
MDSO's Forward Rate of Return (Yacktman) % is ranked higher than
86% of the 939 Companies
in the Global Health Information Services industry.

( Industry Median: 10.12 vs. MDSO: 21.39 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MDSO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -2.7  Med: 5.3 Max: 21.7
Current: 21.39
-2.7
21.7

More Statistics

Revenue (TTM) (Mil) $635.70
EPS (TTM) $ 0.84
Beta1.32
Volatility33.88%
52-Week Range $60.10 - 88.87
Shares Outstanding (Mil)61.35

Analyst Estimate

Dec19 Dec20
Revenue (Mil $) 741 853
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.66 0.97
EPS without NRI ($) 0.66 0.97
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}